Cart
sales@molnova.com
Finrozole
CAS No. 160146-17-8
Finrozole( —— )
Catalog No. M34254 CAS No. 160146-17-8
Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 198 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 456 | Get Quote |
|
| 25MG | 723 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 500MG | 2664 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFinrozole
-
NoteResearch use only, not for human use.
-
Brief DescriptionFinrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
-
DescriptionFinrozole (MPV-2213ad) is a nonsteroidal, orally active and competitive aromatase enzyme inhibitor. Finrozole can be used for urinary symptoms research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAromatase
-
RecptorAromatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number160146-17-8
-
Formula Weight322.34
-
Molecular FormulaC18H15FN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H]([C@H](CC1=CC=C(F)C=C1)O)(C2=CC=C(C#N)C=C2)N3C=NC=N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. O Ahokoski, et al. Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men. Br J Clin Pharmacol. 2001 Dec;52(6):702-4.?
molnova catalog
related products
-
Flavokawain A
Flavokawain A has anti-tumor activity, such as inhibits growth of bladder tumor cells in a nude mice model , prevents the recurrence and progression of non-muscle-invasive urothelial cell carcinoma.
-
Minamestane
Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
-
Letrozole
Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast Y Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme.
